Tag: drug development
Northwestern researchers identify cause of neuron overfiring in ALS and design potential treatment
Researchers at Northwestern Medicine's Les Turner ALS Center have identified the molecular mechanism driving neuronal hyperexcitability in ALS and designed…
AI Integration and Federal Policy Shape Biotech Industry Outlook at BIO 2026
Artificial intelligence and federal regulatory policy dominated discussions at BIO International Convention 2026 in San Diego. Industry leaders expressed cautious…
Neurotensin Receptor 2 Activation Shows Promise in Preventing Heart Failure Progression
Activation of neurotensin receptor 2 in preclinical models significantly reduced pathological changes in heart tissue, suggesting a novel therapeutic target…
Aging Activates Belly Fat Stem Cells: New Clues to Middle-Age Weight Gain
Aging activates specialized stem cells in abdominal tissue that accelerate belly fat production, according to preclinical research. The discovery identifies…
Africa’s Regional Research Hubs: Building Local Capacity for Drug Manufacturing and Health Innovation
Africa needs strategically distributed regional research and development hubs to accelerate local pharmaceutical manufacturing, reduce medicine costs, and build continental…
Biotech Innovation Thrives Despite US Leadership Challenges, Industry Veteran Warns
Biotech industry delivers unprecedented breakthroughs while facing mounting challenges to US leadership from regulatory delays, funding constraints, and international competition.…
Prometheus Biotech Secures Record $12 Billion for AI-Powered Drug Development
Biotech startup Prometheus secures record $12 billion funding for AI-powered drug development platform. Investment represents largest single round for artificial…
New Drug Target for Alzheimer’s Shows Promise in Preclinical Studies
Researchers identified a novel Alzheimer's mechanism and developed an experimental compound that slowed nerve cell loss in mouse models. The…